Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has revolutionized weight loss treatment, helping patients lose an average of 15% of their body weight over 68 weeks according to STEP trial data. The medication works through a step-wise dosing schedule that allows your body to adapt gradually while your healthcare provider monitors your progress. Understanding how these doses are structured helps you set realistic expectations for your personalized weight loss journey.

How Semaglutide Injection Dosing Works

Semaglutide is administered as a once-weekly subcutaneous injection that begins at a low starting dose, then increases incrementally over several months. This titration schedule—typically progressing through 0.25 mg, 0.5 mg, 1 mg, and reaching a target maintenance dose of 2.4 mg—allows your digestive system and appetite-control centers to adjust naturally. Each dose level is usually maintained for four weeks before advancement, though your healthcare provider may adjust this timeline based on your individual response and tolerance.

The gradual escalation strategy significantly reduces the intensity of nausea and gastrointestinal side effects that can occur with GLP-1 receptor agonists. Your body builds tolerance at each step, meaning you experience fewer adjustment symptoms as the dose increases. PlexusDx patients receive clear dosing instructions and can discuss any concerns with their clinician during weekly check-ins throughout the dose escalation period.

Understanding Each Stage of Dose Escalation

The initiation phase begins with a 0.25 mg weekly injection designed to introduce your system to the medication's effects on appetite and blood sugar regulation. During week one through week four, most patients experience mild appetite suppression and may notice subtle changes in food preferences. This low starting dose carries minimal gastrointestinal burden, allowing you to establish a comfortable injection routine before advancing.

Week five through week eight involve progression to 0.5 mg, where appetite suppression becomes more noticeable and many patients begin seeing initial weight loss. The 1 mg dose (weeks nine through twelve) represents a significant step where appetite control deepens and metabolic benefits become measurable. The maintenance dose of 2.4 mg, typically reached by week thirteen or later, is where maximum efficacy is achieved based on clinical trial results showing 25% average weight loss at this level.

What to Expect During Your Dose Adjustment Timeline

During the first month, you may experience reduced appetite, changes in food taste preferences, or mild nausea when introducing the initial 0.25 mg dose. These sensations typically resolve within a few days as your body adapts, and many patients report increased satiety with smaller meal portions. By the end of month one, energy levels often stabilize and patients begin noticing their relationship with food has fundamentally shifted.

Months two through three involve the gradual advancement phases where appetite suppression compounds and sustainable weight loss becomes evident on the scale. Most patients report losing between 5–10 pounds during this period as their caloric intake naturally decreases without restrictive dieting. Around month four when reaching the maintenance dose, weight loss typically accelerates to 1–2 pounds per week for many individuals, aligning with STEP trial observations showing continued progression throughout the first 16 weeks of treatment.

PlexusDx Semaglutide Pricing and Personalization

PlexusDx delivers compounded semaglutide injection from licensed 503A pharmacies starting at $149 per month, with your dose able to increase without any price changes. This flat-rate pricing model means you never face unexpected costs as your medication advances through the standard escalation protocol. No insurance is required, and the medication is HSA/FSA eligible, making precision weight loss therapy accessible to more patients seeking pharmacological support.

For patients wanting deeper insight into their metabolic response potential, the Precision Peptide Genetic Test ($99 add-on after the first treatment month) examines 14 peptide pathways and 150+ genetic insights including GLP1R rs6923761 and GIPR rs1800437 variants. These genetic markers help predict individual response patterns and allow PlexusDx clinicians to tailor your dose progression and monitoring frequency to your unique physiology. All medications are dispensed with detailed dosing schedules and injection technique videos to ensure proper administration throughout your treatment journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does it take to reach the full 2.4 mg maintenance dose?

Most patients reach the 2.4 mg maintenance dose by week 13 or 16, following the standard four-week intervals at each dose level. However, your PlexusDx clinician may adjust this timeline based on your tolerance and weight loss response, potentially extending intervals if you experience significant side effects or accelerating if you tolerate increases easily. Individual progression varies, but the typical total advancement period spans three to four months.

Will my PlexusDx price increase as my semaglutide dose goes up?

No—PlexusDx pricing remains flat throughout your entire dose escalation journey, starting at $149 per month regardless of whether you're on 0.25 mg or 2.4 mg. Your dose may need to go up, but your price won't, making long-term weight management predictable and financially stable. This pricing structure removes barriers to dose optimization and ensures you can reach your therapeutic target without financial surprises.

What happens if I experience side effects during dose escalation?

PlexusDx clinicians monitor your response closely and can pause dose advancement, extend the interval at your current dose, or implement dietary adjustments to manage nausea and GI side effects. Many side effects resolve within days as your body adapts, but your healthcare provider may also recommend specific eating strategies or timing adjustments to improve tolerance. Open communication with your care team ensures your dose escalation feels manageable while maintaining steady progress toward your weight loss goals.

Is compounded semaglutide from PlexusDx as effective as brand-name Wegovy?

PlexusDx compounded semaglutide contains the identical active ingredient as Wegovy and is prepared by licensed 503A compounding pharmacies following strict pharmaceutical standards. Clinical efficacy depends on consistent dosing, proper injection technique, and individual metabolic response rather than brand designation. The main advantage of PlexusDx is accessibility, affordability starting at $149/month, and personalized clinician support throughout your dose escalation without insurance requirements.

How does the Precision Peptide Genetic Test help with my semaglutide dosing?

The Precision Peptide Genetic Test analyzes variants like GLP1R rs6923761 and MC4R rs17782313 to predict your individual response patterns and optimal peptide pathway activation. PlexusDx uses these 150+ genetic insights to potentially recommend dose timing adjustments, complementary lifestyle strategies, or monitoring frequency tailored to your genetic predispositions. This personalization helps maximize your results while minimizing unnecessary trial-and-error during dose escalation.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves